Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice

Background: Once it is established that a jaundiced infant has direct hyperbilirubinemia, the principal diagnostic concern is to differentiate hepatocellular from obstructive cholestasis. Traditional tests such as ultrasonography, percutaneous liver biopsy and technetium 99 m hepatobiliary iminodiac...

Full description

Bibliographic Details
Main Authors: Khalid Shreef, Abdullah Alhelal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:African Journal of Paediatric Surgery
Subjects:
Online Access:http://www.afrjpaedsurg.org/article.asp?issn=0189-6725;year=2016;volume=13;issue=4;spage=181;epage=184;aulast=Shreef
id doaj-062210b3f4174635b6dea63dfe0b5978
record_format Article
spelling doaj-062210b3f4174635b6dea63dfe0b59782020-11-24T23:54:03ZengWolters Kluwer Medknow PublicationsAfrican Journal of Paediatric Surgery0189-67252016-01-0113418118410.4103/0189-6725.194667Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundiceKhalid ShreefAbdullah AlhelalBackground: Once it is established that a jaundiced infant has direct hyperbilirubinemia, the principal diagnostic concern is to differentiate hepatocellular from obstructive cholestasis. Traditional tests such as ultrasonography, percutaneous liver biopsy and technetium 99 m hepatobiliary iminodiacetic acid (HIDA) scan are often not sufficiently discriminating. Definitive exclusion of biliary atresia (BA) in the infant with cholestatic jaundice usually requires mini-laparotomy and intra-operative cholangiography. This approach has many drawbacks because those sick infants are subjected to a time-consuming procedure with the probability of negative surgical exploration. Aim of the Study: The aim of this study was to determine the feasibility of laparoscopic-guided cholecystocholangiography (LGCC) and its accuracy and safety in the diagnosis of BA and thus preventing unnecessary laparotomy in infants whose cholestasis is caused by diseases other than BA. Patients and Methods: Twelve cholestatic infants with direct hyperbilirubinemia subjected to LGCC (age, 7–98 days; mean, 56 days) after ultrasound scan and (99 mTc) HIDA scan and percutaneous liver biopsy failed to provide the definitive diagnosis. Results: One patient had completely absent gall bladder (GB) so the laparoscopic procedure was terminated and laparotomy was done (Kasai operation). Four patients had small size GB; they underwent LGCC that showed patent common bile duct with atresia of common hepatic duct, so laparotomy and Kasai operation was performed. Seven patients had well-developed GB, LGCC revealed patent biliary tree, so laparoscopic liver biopsies were taken for histopathology. Five of those patients had neonatal hepatitis, and two had cholestasis as a complication of prolonged TPN. No perioperative complications or mortalities were recorded. Conclusion: When the diagnosis neonatal cholestasis remains elusive after traditional investigations, LGCC is an accurate and simple method for differentiating BA from hepatocellular causes.http://www.afrjpaedsurg.org/article.asp?issn=0189-6725;year=2016;volume=13;issue=4;spage=181;epage=184;aulast=ShreefBiliary atresialaparoscopyneonatal cholestatic jaundice
collection DOAJ
language English
format Article
sources DOAJ
author Khalid Shreef
Abdullah Alhelal
spellingShingle Khalid Shreef
Abdullah Alhelal
Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
African Journal of Paediatric Surgery
Biliary atresia
laparoscopy
neonatal cholestatic jaundice
author_facet Khalid Shreef
Abdullah Alhelal
author_sort Khalid Shreef
title Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
title_short Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
title_full Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
title_fullStr Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
title_full_unstemmed Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
title_sort evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
publisher Wolters Kluwer Medknow Publications
series African Journal of Paediatric Surgery
issn 0189-6725
publishDate 2016-01-01
description Background: Once it is established that a jaundiced infant has direct hyperbilirubinemia, the principal diagnostic concern is to differentiate hepatocellular from obstructive cholestasis. Traditional tests such as ultrasonography, percutaneous liver biopsy and technetium 99 m hepatobiliary iminodiacetic acid (HIDA) scan are often not sufficiently discriminating. Definitive exclusion of biliary atresia (BA) in the infant with cholestatic jaundice usually requires mini-laparotomy and intra-operative cholangiography. This approach has many drawbacks because those sick infants are subjected to a time-consuming procedure with the probability of negative surgical exploration. Aim of the Study: The aim of this study was to determine the feasibility of laparoscopic-guided cholecystocholangiography (LGCC) and its accuracy and safety in the diagnosis of BA and thus preventing unnecessary laparotomy in infants whose cholestasis is caused by diseases other than BA. Patients and Methods: Twelve cholestatic infants with direct hyperbilirubinemia subjected to LGCC (age, 7–98 days; mean, 56 days) after ultrasound scan and (99 mTc) HIDA scan and percutaneous liver biopsy failed to provide the definitive diagnosis. Results: One patient had completely absent gall bladder (GB) so the laparoscopic procedure was terminated and laparotomy was done (Kasai operation). Four patients had small size GB; they underwent LGCC that showed patent common bile duct with atresia of common hepatic duct, so laparotomy and Kasai operation was performed. Seven patients had well-developed GB, LGCC revealed patent biliary tree, so laparoscopic liver biopsies were taken for histopathology. Five of those patients had neonatal hepatitis, and two had cholestasis as a complication of prolonged TPN. No perioperative complications or mortalities were recorded. Conclusion: When the diagnosis neonatal cholestasis remains elusive after traditional investigations, LGCC is an accurate and simple method for differentiating BA from hepatocellular causes.
topic Biliary atresia
laparoscopy
neonatal cholestatic jaundice
url http://www.afrjpaedsurg.org/article.asp?issn=0189-6725;year=2016;volume=13;issue=4;spage=181;epage=184;aulast=Shreef
work_keys_str_mv AT khalidshreef evaluationoftheuseoflaparoscopicguidedcholecystocholangiographyandliverbiopsyindefinitivediagnosisofneonatalcholestaticjaundice
AT abdullahalhelal evaluationoftheuseoflaparoscopicguidedcholecystocholangiographyandliverbiopsyindefinitivediagnosisofneonatalcholestaticjaundice
_version_ 1725467558749929472